Return to Home Incidence > Table

Incidence Rates Table

Data Options

Incidence Rate Report by State

Colon & Rectum (Late Stage^), 2017-2021

All Races (includes Hispanic), Both Sexes, Ages 50+

Sorted by Name

State
 sort alphabetically by name descending
Age-Adjusted Incidence Rate
cases per 100,000
(95% Confidence Interval)
 sort by rate descending
CI*Rank
(95% Confidence Interval)
 sort by CI rank descending
Average Annual Count
 sort by count descending
Percent of Cases with Late Stage
 sort by percent late descending
US (SEER+NPCR) 1 64.2 (64.0, 64.4) N/A 72,697 59.1
Alabama 6 64.5 (62.8, 66.1) 24 (18, 30) 1,186 54.1
Alaska 6 75.7 (70.2, 81.5) 5 (2, 17) 157 60.7
Arizona 6 55.5 (54.2, 56.8) 45 (40, 48) 1,430 58.3
Arkansas 6 74.3 (72.0, 76.7) 6 (3, 11) 809 60.0
California 3 56.1 (55.5, 56.7) 43 (40, 47) 7,141 56.0
Colorado 6 56.9 (55.3, 58.5) 42 (35, 47) 1,026 61.4
Connecticut 3 55.1 (53.3, 56.9) 46 (39, 48) 750 55.5
Delaware 6 58.4 (55.0, 62.0) 39 (24, 48) 227 58.9
District of Columbia 6 55.7 (50.9, 60.8) 44 (26, 50) 103 52.8
Florida 6 63.2 (62.4, 63.9) 26 (22, 31) 5,656 59.0
Georgia 3 67.7 (66.4, 68.9) 16 (12, 22) 2,295 57.4
Hawaii 3 63.1 (60.1, 66.2) 27 (17, 38) 352 57.0
Idaho 3 65.0 (62.1, 68.0) 22 (13, 32) 393 61.7
Illinois 3 71.6 (70.5, 72.8) 9 (6, 13) 3,190 60.8
Iowa 3 66.3 (64.2, 68.4) 20 (12, 27) 772 55.8
Kansas 6 69.7 (67.3, 72.0) 13 (7, 21) 698 59.7
Kentucky 3 77.3 (75.3, 79.2) 3 (2, 7) 1,243 56.4
Louisiana 3 76.4 (74.4, 78.4) 4 (2, 8) 1,222 57.5
Maine 6 58.6 (55.8, 61.5) 37 (28, 47) 346 57.8
Maryland 6 61.6 (60.1, 63.1) 31 (24, 36) 1,319 59.3
Michigan 6 62.5 (61.4, 63.7) 29 (23, 33) 2,339 59.7
Minnesota 6 60.1 (58.6, 61.7) 33 (28, 41) 1,189 56.5
Mississippi 6 86.6 (84.0, 89.2) 1 (1, 1) 902 61.2
Missouri 6 71.9 (70.3, 73.5) 8 (5, 13) 1,614 61.9
Montana 6 66.3 (62.7, 70.0) 19 (9, 31) 274 60.3
Nebraska 6 66.7 (63.9, 69.6) 18 (10, 29) 441 56.9
Nevada 6 57.9 (55.8, 60.1) 41 (31, 46) 602 55.8
New Hampshire 6 59.8 (56.9, 62.9) 35 (23, 45) 327 60.8
New Jersey 3 65.8 (64.6, 67.1) 21 (16, 25) 2,201 57.3
New Mexico 3 54.4 (52.0, 56.8) 47 (39, 49) 420 56.4
New York 3 60.0 (59.2, 60.8) 34 (30, 39) 4,373 56.5
North Carolina 6 64.1 (62.9, 65.3) 25 (20, 30) 2,346 61.4
North Dakota 6 70.9 (66.3, 75.8) 10 (3, 24) 182 60.9
Ohio 6 70.7 (69.6, 71.8) 11 (7, 14) 3,079 60.6
Oklahoma 6 67.3 (65.3, 69.3) 17 (11, 24) 902 56.0
Oregon 6 58.5 (56.7, 60.3) 38 (31, 44) 893 60.2
Pennsylvania 6 68.9 (67.9, 69.9) 14 (10, 19) 3,506 61.7
Puerto Rico 6 14.6 (14.1, 15.1) N/A 676 48.9
Rhode Island 6 57.9 (54.6, 61.4) 40 (27, 48) 238 59.2
South Carolina 6 62.8 (61.2, 64.4) 28 (21, 34) 1,200 60.4
South Dakota 6 74.3 (70.0, 78.8) 7 (2, 16) 235 62.8
Tennessee 6 70.1 (68.6, 71.7) 12 (7, 17) 1,709 60.8
Texas 3 68.6 (67.8, 69.4) 15 (11, 19) 5,748 60.0
Utah 3 48.4 (46.3, 50.7) 50 (48, 50) 383 58.1
Vermont 6 53.4 (49.4, 57.6) 48 (36, 50) 140 56.2
Virginia 6 58.8 (57.6, 60.1) 36 (32, 42) 1,733 58.5
Washington 5 60.2 (58.9, 61.6) 32 (29, 40) 1,528 60.5
West Virginia 6 78.6 (75.7, 81.5) 2 (2, 7) 585 59.4
Wisconsin 6 62.3 (60.8, 63.9) 30 (22, 35) 1,349 60.9
Wyoming 6 64.5 (59.6, 69.8) 23 (8, 41) 131 60.2
Indiana 6
data not available
N/A
data not available
data not available
Notes:
Created by statecancerprofiles.cancer.gov on 11/04/2024 8:27 pm.

State Cancer Registries may provide more current or more local data.
Trend
Rising when 95% confidence interval of average annual percent change is above 0.
Stable when 95% confidence interval of average annual percent change includes 0.
Falling when 95% confidence interval of average annual percent change is below 0.

† Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ... , 80-84, 85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Rates calculated using SEER*Stat. Population counts for denominators are based on Census populations as modified by NCI. The US Population Data File is used for SEER and NPCR incidence rates.

Rates are computed using cancers classified as malignant based on ICD-O-3. For more information see malignant.html.

^ Late Stage is defined as cases determined to be regional or distant. Due to changes in stage coding, Combined Summary Stage (2004+) is used for data from Surveillance, Epidemiology, and End Results (SEER) databases and Merged Summary Stage is used for data from National Program of Cancer Registries databases. Due to the increased complexity with staging, other staging variables maybe used if necessary.
⋔ Results presented with the CI*Rank statistics help show the usefulness of ranks. For example, ranks for relatively rare diseases or less populated areas may be essentially meaningless because of their large variability, but ranks for more common diseases in densely populated regions can be very useful. More information about methodology can be found on the CI*Rank website.

Data not available for this combination of data selections.
1 Source: National Program of Cancer Registries and Surveillance, Epidemiology, and End Results SEER*Stat Database - United States Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute. Based on the 2023 submission.
3 Source: SEER November 2023 submission. State Cancer Registry also receives funding from CDC's National Program of Cancer Registries.
5 Source: National Program of Cancer Registries and Surveillance, Epidemiology, and End Results SEER*Stat Database - United States Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute. Based on the 2023 submission.
6 Source: National Program of Cancer Registries SEER*Stat Database - United States Department of Health and Human Services, Centers for Disease Control and Prevention (based on the 2023 submission).

Data for the United States does not include data from Indiana.
Data for the United States does not include Puerto Rico.
CI*Rank data for Puerto Rico is not available.

Return to Top